Cancer3D: Understanding cancer mutations through protein structures

Nucleic Acids Research

Volumn 43, Issue D1, 2015, Pages D968-D973

  Porta Pardo, Eduard ^a   Hrabe, Thomas ^a   Godzik, Adam ^a  

^a BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; N [3 (5 CHLORO 1H PYRROLO[2,3 B]PYRIDINE 3 CARBONYL) 2,4 DIFLUOROPHENYL]PROPANESULFONAMIDE; VEMURAFENIB; ANTINEOPLASTIC AGENT; ISOPROTEIN; TUMOR MARKER; TUMOR PROTEIN;

ARTICLE; BIOINFORMATICS; CANCER 3D DATABASE; CANCER GENETICS; CLIENT SERVER APPLICATION; COMPUTER INTERFACE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DATA ANALYSIS; DATA ANALYSIS SOFTWARE; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; DRUG TARGETING; GENE FREQUENCY; GENE IDENTIFICATION; GENE MAPPING; GENE STRUCTURE; GENETIC ALGORITHM; GENETIC DATABASE; HUMAN; IC50; IMAGE DISPLAY; MALIGNANT NEOPLASTIC DISEASE; METASTATIC MELANOMA; MISSENSE MUTATION; MOLECULAR IMAGING; MUTATIONAL ANALYSIS; PHARMACOGENOMICS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; SOMATIC MUTATION; STRUCTURAL PROTEOMICS; STRUCTURE ANALYSIS; SYSTEM ANALYSIS; THREE DIMENSIONAL IMAGING; CHEMISTRY; GENETICS; INTERNET; METABOLISM; PROTEIN CONFORMATION; PROTEIN DATABASE;

ANTINEOPLASTIC AGENTS; BIOMARKERS, TUMOR; DATABASES, PROTEIN; INTERNET; MUTATION, MISSENSE; NEOPLASM PROTEINS; PROTEIN CONFORMATION; PROTEIN ISOFORMS;

EID: 84941627653     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gku1140     Document Type: Article

References (27)

1. Kandoth, C., McLellan, M. D., Vandin, F., Ye, K., Niu, B., Lu, C., Xie, M., Zhang, Q., McMichael, J. F., Wyczalkowski, M. A. et al. (2013) Mutational landscape and significance across 12 major cancer types. Nature, 502, 333-339.
2. Kelloff, G. J. and Sigman, C. C. (2012) Cancer biomarkers: selecting the right drug for the right patient. Nat. Rev. Drug Discov., 11, 201-214.
3. Yuan, Y., Van Allen, E. M., Omberg, L., Wagle, N., Amin-Mansour, A., Sokolov, A., Byers, L. A., Xu, Y., Hess, K. R., Diao, L. et al. (2014) Assessing the clinical utility of cancer genomic and proteomic data across tumor types. Nat. Biotechnol., 32, 644-652.
4. Valencia, A. and Hidalgo, M. (2012) Getting personalized cancer genome analysis into the clinic: the challenges in bioinformatics. Genome Med., 4, 61.
5. Cancer Genome Atlas Research, N., Weinstein, J. N., Collisson, E. A., Mills, G. B., Shaw, K. R., Ozenberger, B. A., Ellrott, K., Shmulevich, I., Sander, C. and Stuart, J. M. (2013) The Cancer Genome Atlas Pan-Cancer analysis project. Nat. Genet., 45, 1113-1120.
6. Barretina, J., Caponigro, G., Stransky, N., Venkatesan, K., Margolin, A. A., Kim, S., Wilson, C. J., Lehar, J., Kryukov, G. V., Sonkin, D. et al. (2012) The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature, 483, 603-607.
7. Cline, M. S., Craft, B., Swatloski, T., Goldman, M., Ma, S., Haussler, D. and Zhu, J. (2013) Exploring TCGA Pan-Cancer data at the UCSC Cancer Genomics Browser. Sci. Rep., 3, 2652.
8. Bulusu, K. C., Tym, J. E., Coker, E. A., Schierz, A. C. and Al-Lazikani, B. (2014) canSAR: updated cancer research and drug discovery knowledgebase. Nucleic Acids Res., 42, D1040-D1047.
9. Cerami, E., Gao, J., Dogrusoz, U., Gross, B. E., Sumer, S. O., Aksoy, B. A., Jacobsen, A., Byrne, C. J., Heuer, M. L., Larsson, E. et al. (2012) The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov., 2, 401-404.
10. Forbes, S. A., Tang, G., Bindal, N., Bamford, S., Dawson, E., Cole, C., Kok, C. Y., Jia, M., Ewing, R., Menzies, A. et al. (2010) COSMIC (the Catalogue of Somatic Mutations in Cancer): a resource to investigate acquired mutations in human cancer. Nucleic Acids Res., 38, D652-D657.
11. Zhong, Q., Simonis, N., Li, Q. R., Charloteaux, B., Heuze, F., Klitgord, N., Tam, S., Yu, H., Venkatesan, K., Mou, D. et al. (2009) Edgetic perturbation models of human inherited disorders. Mol. Syst. Biol., 5, 321.
12. Wang, X., Wei, X., Thijssen, B., Das, J., Lipkin, S. M. and Yu, H. (2012) Three-dimensional reconstruction of protein networks provides insight into human genetic disease. Nat. Biotechnol., 30, 159-164.
13. Porta-Pardo, E. and Godzik, A. (2014) e-Driver: a novel method to identify protein regions driving cancer. Bioinformatics, 30, 3109-3114.
14. Nehrt, N. L., Peterson, T. A., Park, D. and Kann, M. G. (2012) Domain landscapes of somatic mutations in cancer. BMC Genomics, 13(Suppl. 4), S9.
15. Porta-Pardo, E. and Godzik, A. (2014) Analysis of individual protein regions provides novel insights on cancer pharmacogenomics. PLoS Comp. Biol., in press.
16. Punta, M., Coggill, P. C., Eberhardt, R. Y., Mistry, J., Tate, J., Boursnell, C., Pang, N., Forslund, K., Ceric, G., Clements, J. et al. (2012) The Pfam protein families database. Nucleic Acids Res., 40, D290-D301.
17. Xu, D., Jaroszewski, L., Li, Z. and Godzik, A. (2014) AIDA: ab initio domain assembly server. Nucleic Acids Res., 42, W308-W313.
18. Flicek, P., Amode, M. R., Barrell, D., Beal, K., Brent, S., Carvalho-Silva, D., Clapham, P., Coates, G., Fairley, S., Fitzgerald, S. et al. (2012) Ensembl 2012. Nucleic Acids Res., 40, D84-D90.
19. Prilusky, J., Felder, C. E., Zeev-Ben-Mordehai, T., Rydberg, E. H., Man, O., Beckmann, J. S., Silman, I. and Sussman, J. L. (2005) FoldIndex: a simple tool to predict whether a given protein sequence is intrinsically unfolded. Bioinformatics, 21, 3435-3438.
20. Keshava Prasad, T. S., Goel, R., Kandasamy, K., Keerthikumar, S., Kumar, S., Mathivanan, S., Telikicherla, D., Raju, R., Shafreen, B., Venugopal, A. et al. (2009) Human Protein Reference Database-2009 update. Nucleic Acids Res., 37, D767-D772.
21. Altschul, S. F., Gish, W., Miller, W., Myers, E. W. and Lipman, D. J. (1990) Basic local alignment search tool. J. Mol. Biol., 215, 403-410.
22. Bollag, G., Tsai, J., Zhang, J., Zhang, C., Ibrahim, P., Nolop, K. and Hirth, P. (2012) Vemurafenib: the first drug approved for BRAF-mutant cancer. Nat. Rev. Drug Discov., 11, 873-886.
23. Jaroszewski, L., Li, Z., Cai, X. H., Weber, C. and Godzik, A. (2011) FFAS server: novel features and applications. Nucleic Acids Res., 39, W38-W44.
24. Ciriello, G., Miller, M. L., Aksoy, B. A., Senbabaoglu, Y., Schultz, N. and Sander, C. (2013) Emerging landscape of oncogenic signatures across human cancers. Nat. Genet., 45, 1127-1133.
25. Supek, F., Minana, B., Valcarcel, J., Gabaldon, T. and Lehner, B. (2014) Synonymous mutations frequently act as driver mutations in human cancers. Cell, 156, 1324-1335.
26. International Cancer Genome, C., Hudson, T. J., Anderson, W., Artez, A., Barker, A. D., Bell, C., Bernabe, R. R., Bhan, M. K., Calvo, F., Eerola, I. et al. (2010) International network of cancer genome projects. Nature, 464, 993-998.
27. Yang, W., Soares, J., Greninger, P., Edelman, E. J., Lightfoot, H., Forbes, S., Bindal, N., Beare, D., Smith, J. A., Thompson, I. R. et al. (2013) Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells. Nucleic Acids Res., 41, D955-D961.